Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 3,000 shares at $12.20 ($36K) on 2007-06-01, disclosed to the SEC on 2007-06-04.
Scheduled sale ($36k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.05 | 500 | $6K | 16.6% |
| 2 | $12.10 | 1,100 | $13K | 36.6% |
| 3 | $12.12 | 500 | $6K | 16.7% |
| 4 | $12.15 | 400 | $5K | 13.4% |
| 5 | $12.20 | 500 | $6K | 16.8% |
| Total | $12.12 avg | 3,000 |
| $36K |
| 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |